Solara Active Pharma [SOLARAPP] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Solara Active Pharma Sciences Ltd.

BSE
Loading...

Aarti Drugs Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Solara Active Pharma Sciences Ltd. wins in 8 metrics, Aarti Drugs Ltd. wins in 11 metrics, with 0 ties. Aarti Drugs Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Solara Active Pharma Sciences Ltd. Aarti Drugs Ltd. Better
P/E Ratio (TTM) 2,428.57 16.37 Aarti Drugs Ltd.
Price-to-Book Ratio 1.25 2.43 Solara Active Pharma Sciences Ltd.
Debt-to-Equity Ratio 72.58 39.05 Aarti Drugs Ltd.
PEG Ratio -24.26 1.75 Aarti Drugs Ltd.
EV/EBITDA 10.57 12.87 Solara Active Pharma Sciences Ltd.
Profit Margin (TTM) 0.04% 8.03% Aarti Drugs Ltd.
Operating Margin (TTM) 7.72% 6.16% Solara Active Pharma Sciences Ltd.
EBITDA Margin (TTM) 7.72% 6.16% Solara Active Pharma Sciences Ltd.
Return on Equity 0.05% 12.28% Aarti Drugs Ltd.
Return on Assets (TTM) 2.92% 6.53% Aarti Drugs Ltd.
Free Cash Flow (TTM) $1.73B $674.22M Solara Active Pharma Sciences Ltd.
Dividend Yield N/A 0.53% N/A
1-Year Return 22.59% -14.30% Solara Active Pharma Sciences Ltd.
Price-to-Sales Ratio (TTM) 1.65 1.31 Aarti Drugs Ltd.
Enterprise Value $21.80B $38.50B Aarti Drugs Ltd.
EV/Revenue Ratio 1.70 1.53 Aarti Drugs Ltd.
Gross Profit Margin (TTM) 54.11% 35.74% Solara Active Pharma Sciences Ltd.
Revenue per Share (TTM) $333 $276 Solara Active Pharma Sciences Ltd.
Earnings per Share (Diluted) $0.14 $22.09 Aarti Drugs Ltd.
Beta (Stock Volatility) 1.12 0.24 Aarti Drugs Ltd.

Solara Active Pharma Sciences Ltd. vs Aarti Drugs Ltd. Stock Performance Analysis

Loading Price Chart...

SOLARAPP
AARTIDRUGS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Solara Active Pharma Sciences Ltd.-0.31%-3.50%-4.34%63.68%63.68%63.68%
Aarti Drugs Ltd.-0.94%-3.20%-4.41%4.98%-7.86%-9.18%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Solara Active Pharma Sciences Ltd.22.59%90.07%90.07%90.07%90.07%90.07%
Aarti Drugs Ltd.-14.30%-16.64%-49.93%230.78%2,195.72%3,618.48%

Performance & Financial Health Analysis: Solara Active Pharma Sciences Ltd. vs Aarti Drugs Ltd.

MetricSOLARAPPAARTIDRUGS
Market Information
Market Cap i₹21.12B₹33.96B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i578141,078
90 Day Avg. Volume i614139,729
Last Close₹446.85₹374.85
52 Week Range₹215.55 - ₹560.85₹318.95 - ₹564.05
% from 52W High-20.33%-33.54%
All-Time High₹560.85 (Dec 09, 2024)₹1,026.95 (Oct 05, 2020)
% from All-Time High-20.33%-63.50%
Growth Metrics
Quarterly Revenue Growth0.04%0.08%
Quarterly Earnings Growth-0.12%0.09%
Financial Health
Profit Margin (TTM) i0.00%0.08%
Operating Margin (TTM) i0.08%0.06%
Return on Equity (TTM) i0.00%0.12%
Debt to Equity (MRQ) i72.5839.05
Cash & Liquidity
Book Value per Share (MRQ)₹271.86₹148.52
Cash per Share (MRQ)₹1.02₹2.69
Operating Cash Flow (TTM) i₹2.13B₹2.83B
Levered Free Cash Flow (TTM) i₹-173,124,992₹1.68B
Dividends
Last 12-Month Dividend Yield iN/A0.53%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Solara Active Pharma Sciences Ltd. vs Aarti Drugs Ltd.

MetricSOLARAPP (Aug 03, 2025)AARTIDRUGS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i2,428.5716.37
Forward P/E iN/A14.64
PEG Ratio i-24.261.75
Price to Sales (TTM) i1.651.31
Price to Book (MRQ) i1.252.43
Market Capitalization
Market Capitalization i₹21.12B₹33.96B
Enterprise Value i₹21.80B₹38.50B
Enterprise Value Metrics
Enterprise to Revenue i1.701.53
Enterprise to EBITDA i10.5712.87
Risk & Other Metrics
Beta i1.120.24
Book Value per Share (MRQ) i₹271.86₹148.52

Financial Statements Comparison: Solara Active Pharma Sciences Ltd. vs Aarti Drugs Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSOLARAPP (2025)AARTIDRUGS (2025)
Revenue/Sales i12.84B23.69B
Cost of Goods Sold i6.26B18.90B
COGS % of Revenue i48.8%79.8%
Gross Profit i6.57B4.79B
Gross Margin i51.2%20.2%
Research & Development iN/AN/A
Operating Income (EBIT) i1.07B2.43B
Operating Margin i8.3%10.3%
EBITDA i2.15B3.07B
EBITDA Margin i16.7%13.0%
Pre-Tax Income i5.40M2.12B
Pre-Tax Income % of Revenue i0.0%8.9%
Income Tax i0436.74M
Income Tax % of Revenue i0.0%1.8%
Net Income (Profit) i5.40M1.68B
Profit Margin i0.0%7.1%

Balance Sheet & Liquidity Metrics

MetricSOLARAPP (2025)AARTIDRUGS (2025)
Cash & Equivalents i39.50M45.77M
Total Current Assets i7.29B13.38B
Total Current Assets % of Revenue i56.8%56.5%
Total Current Liabilities i9.44B8.37B
Total Current Liabilities % of Revenue i73.5%35.3%
Long-Term Debt i1.32B2.86B
Long-Term Debt % of Revenue i10.3%12.1%
Total Shareholders Equity i10.97B13.69B
Retained Earnings iN/A12.40B
Retained Earnings % of Revenue i0.0%52.4%
Property, Plant & Equipment i7.96B27.03M

Cash Flow Statement Comparison

MetricSOLARAPP (2025)AARTIDRUGS (2025)
Operating Cash Flow i1.74B2.83B
Operating Cash Flow % of Revenue i13.6%11.9%
Capital Expenditures i3.80M480,000
Free Cash Flow i1.73B674.22M
FCF Margin i13.5%2.8%
Debt Repayment i-1.11B-776.08M
Common Stock Repurchase iN/A-598.50M

Short Interest & Institutional Ownership Analysis

MetricSOLARAPPAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i48.05M91.27M
Float Shares i27.66M35.37M
% Held by Insiders i0.00%59.48%
% Held by Institutions i4.46%11.04%
% Held by Public i95.54%29.48%

Dividend Analysis & Yield Comparison: Solara Active Pharma Sciences Ltd. vs Aarti Drugs Ltd.

MetricSOLARAPPAARTIDRUGS
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.53%
3-Year Avg Annual Dividend iN/A₹1.33
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A₹4.00
Ex-Dividend DateN/AFeb 09, 2026